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Summary 
The relationship between the structure of the T cell antigen receptor (TCR)-CD3 complex and 
development of NKI.1 + T cells was investigated. The TCR complex of freshly isolated NKI.1 + 
TCR-c~/{3 + thymocytes contained CD3~" homodimers and CD3~'-FcR7 heterodimers, whereas 
that of the majority of NKI.1-  T calls did not contain FcRT. The function of CD3~" and FcR7 
in the development of NKI.1 + T cells was determined by analyzing CD3~'- and FcRT-ddicient 
mice. The NKI.1 + T  ceils from wild-type and CD3~'-deficient mice had equal levels of CD3 
expression. However, the development of NKI.1 + TCR-cx/B + T  cells was almost completely 
disrupted in thymus and spleen in CD3~'-deficient mice, whereas no alteration was observed 
in FcRT-deficient mice. In contrast, the number of novel NKI.1 + TCR-7/15 + thymocytes ex- 
pressing a surface phenotype similar to NKI.1 + TCR-cdI3 + thymocytes increased approximately 
six times in CD3~'-deficient mice. These findings establish  the distinct roles of the CD3~" chain 
in the development of the following different thymic T  call compartments: NKI.1-  TCR +, 
NKI.1 + TCR-cUI3 +, and NKI.1 + TCR-7//5 + thymocytes, which cannot be replaced by CD3~/ 
or Fcg7 chains. 
T  cell population  expressing NKI.1,  a marker previ- 
ously thought to be specific for natural killer cells, has 
been found in CD4+CD8 -  T cells and CD4-CD8-  T cells 
(1-4).  The  NKI.1 +  TCR-oUj3 +  T  cells  express  skewed 
TCR Vc~ (5) and VB (1, 2, 4) families.  Recently, a similar 
T  cell population with a skewed TCR repertoire was also 
identified in human lymphocytes (5-7). These T cells secrete 
several kinds of lymphokines, such as Ib2, II.-4, and IFN-7 
(8,  9).  Furthermore, we have shown that  NKI.1 + TCR- 
ci/B +  thymocytes  are  the  only  population  within  the 
thymus that expresses Fas ligand and is cytotoxic against im- 
mature CD4 +CD8 + thymocytes expressing  Fas antigen (10, 
11). NKI.1 + TCR-ci/13 + thymocytes appear to be an impor- 
tant population that may regulate the development of the 
immune system by secreting several different lymphokines 
(12) or by killing Fas-expressing cells (11). Although both 
NKI.1 +  CD4+CD8 -  and  NKI.1 +  CD4-CD8-  T  cells 
were shown to be selected by 132-microglobulin-associated 
MHC class I antigen (13-16), it has remained unclear what 
antigen the NKI.1 + TCR-ci/B + T cells recognize and how 
the NKI.1 + TCR-cx/13 + T  cells develop. 
Recently, IL-2-activated NKI.1 +  TCR-cx//3 + thymocytes 
were shown to express TCR complexes associated with FcR3, 
homodimers (17) similarly to CD8c~/ci + TCR-7/<3 + T cells 
in intestinal intraepithelial  lymphocytes (18-20). These studies 
raised the possibility that NKI.1 + TCR-cUB + thymocytes 
may have TCR complexes and signaling functions distinct 
from conventional NKI.1-  T cells. In the present study, to 
understand  the  signals  required  for  the  development  of 
NKI.1 + TCR-cx/{3 + T cells, we analyzed these populations 
in CD3~'- (21) and FcRT-deficient mice (22). CD3~'was re- 
quired for the development of these T ceUs, although FcR7 
ddidency did not alter their development. On the other hand, 
the number of NKI.1 + TCR-7/~ + thymocytes significantly 
increased in CD3~'-ddident mice. These findings demonstrated 
that CD3~" has distinct roles in the development of not only 
the major NKI.1-  T cells (20, 21, 23) but also of NKI.1 + 
T  cells. 
Materials and Methods 
Mice.  CD3~'-deficient mice were made as previously described 
(21). FcRT-defident mice were kindly provided  by Dr. J. V. Ravetch 
(The Rockefeller University, New York) (22). These mice were 
maintained in our animal facility  and back-crossed  to C57BL/6 mice 
six times for CD3~'-defacient mice and three times for FcRT-defident 
mice, and NKI.1 expression was confirmed for all mice. 
Cell Preparation.  NKI.1 § TCR-~x/B  + thymocytes were pre- 
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of NKI.1 + TCR-c~/~ § thymocytes was >99%. LN T cells were 
prepared by removing surface Ig + B cells by magnetic particles 
coupled with goat anti-mouse IgG Ab (Advanced  Magnetics, Inc., 
Cambridge, MA). 
Immunoprecipitation and  Two-dimensional SDS-PAGE  Analysis. 
Immunoprecipitation  was carried out basically  as described  by Kim 
et al. (24). Briefly,  3  x  l& purified NKI.1 § TCR-odB + thymo- 
cytes and LN T cells were solubilized  in lysis  buffer (1% digitonin, 
50 mM Tris-HC1, pH 7.6, 300 mM NaC1, 10 #g/ml aprotinin, 
10 #g/ml leupeptin, 2.5 #g/ml antipain, 2.5 #g/ml chymostatin, 
10 #g/ml pepstatin A, 1 mM PMSF, and 10 mM iodoacetamide). 
Immunoprecipitation was performed with anti-CD3 (2Cll) mAb 
precoupled by dimethylpimelimidate  to protein A Sepharose (Phar- 
macia Biotech, Inc., Piscataway,  NJ). The total precipitates were 
biotinylated as previously described (18). After biotinylation, im- 
munoprecipitates  were  resolved by  two-dimensional  non- 
reducing-reducing SDS-PAGE and transferred onto polyvinylidene 
fluoride  membrane. The biotinylated  protein on the membrane was 
detected  by enzyme chemiluminescence  as described  previously  (18). 
FACS  |  Analysis.  1  x  106  thymocytes or red cell-depleted 
splenocytes  were stained  with FITC-anti-heat stable  antigen (HSA) 
mAb, PE-anti-NKl.1  mAb, and biotin-anti-CD3,  TCR-od~ or 
TCR-qr/c5 mAb (all from Pharmingen, San Diego, CA), followed 
by Tricolor-streptavidin  (Caltag Laboratories, San Francisco, CA). 
For analysis  of  various surface  marker expressions, thymocytes  were 
stained with FITC-anti-HSA mAb, PE-anti-NKl.1 mAb, and bio- 
tin-anti-CD4, -CDS, -CD44,-MEL-14 (LECAM-1) (all from Phar- 
mingen)-IL-2RB  (kindly provided by Dr.  Miyasaka), or-IL--TR 
mAb (gratefully received  from Dr. Nishikawa, Kyoto University, 
Japan), followed by Tricolor-streptavidin. The stained cells were 
analyzed by  FACScan  |  (Becton Dickinson  &  Co.,  Mountain 
View, CA). 
Results 
Association ofFcR 7  with the TCR Complexes of  Freshly Iso- 
lated NKI.1 + TCR-cr/~ + Thymocytes.  Recent analysis by 
S. Koyasu revealed that II~2-activated NKI.1 + TCR-ot/B + 
T cells express unique TCR complexes associated with FcR3' 
homodimers (17). However, because of the limited number 
of these cells isolated from mice, analysis of the TCR com- 
plexes in freshly isolated NKI.1 + TCR-odB + T  cells has 
been difficult. In the present study, we applied a newly de- 
veloped sensitive labeling method (24) for analyzing the TCR 
complexes  of freshly isolated NKI.1 + TCR-ot/B + thymo- 
cytes. As shown in Fig. 1, immunoprecipitation of the TCR 
complexes  of NKI.1 + TCR-c~/~ + thymocytes with anti- 
CD3e  mAb  showed that  the complexes  contained CD3~" 
homodimers and CD3~'-FcR3, heterodimers.  However, FcR3, 
homodimers, which were observed  in the TCR complexes 
of ILo2-activated NKI.1 § T  cells (17), were not detected in 
the complexes  of the freshly isolated NKI.1 §  TCR-ot/~ + 
thymocytes. On the other hand, only CD3~"  homodimers were 
detected in TCR complexes ofLN T cells as a representative 
population of the NKI.1-  conventional T  cells. Therefore, 
NKI.1 + TCR-ot/B + thymocytes seemed to possess a unique 
composition of the TCR-CD3 complexes, perhaps reflecting 
a distinct TCR signaling capability of these cells. 
Requirement  of CD3~'for  Development  of NKI.1 + TCR. 
ce/fl + T  Cells.  We next examined the functional differ- 
ences between CD3~" and FcR3' expressed on NKI.1 + TCR- 
ot/~ + T  cells in their development by using CD3~'- (21) and 
FcRq,-deficient  mice (22).  Because NKI.1 + CD3 + thymo- 
cytes do not express HSA antigen in normal mice (1, 3, 4, 
9) and in CD3~'-deficient  mice (data not shown), we ana- 
lyzed the expression  of NKI.1 and TCR on HSA-  thymo- 
cytes. As shown in Fig. 2 A, NKI.1 + thymocytes from ~'+/- 
and ~'-/-  mice expressed  the same level of CD3. However, 
the number of NKI.1 + TCR-ot/B + cells was found to be 
severely reduced in ~'-/-  mice.  Staining the cells with anti- 
V~8 mAb showed a similar result (data not shown).  The 
proportion of NKI.1 + TCR-ot//3 + thymocytes to NKI.1- 
TCR-ot/B + thymocytes in CD3g'-defident mice decreased to 
one-third of that in wild-type mice.  This indicates that the 
reduction of the cell number of NKI.1 + TCR-ot/B + cells 
in  CD3~'-deficient  mice  was  more  drastic  than  that  of 
NKI.1-  TCR-c~/B + cells. When NKI.1 §  CD3 + cells in 
~'-/-  mice were  stained with anti-TCR-3,//~ mAb,  it was 
found that most of these cells were TCR-3,//~ + . To under- 
stand the composition of the thymocytes in ~'-/-  mice,  the 
total cell numbers of the NKI.1 + TCR-c~/~/+  and NKI.1 + 
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Figure  1.  Involvement  of the FcR"/ 
chain in the TCR complex  of freshly 
isolated NKI.I+ TCK-ot/~+ thymo- 
cytes. Total  cell lysate  from 3-5  x 106 
NKI.1  + TCR-ot//J+ thymocytes  and 
LN T cells was precipitated  with anti- 
CD3e mAb. The immunoprecipitates 
were biotinylated  on beads and ana- 
lyzed  by two-dimensional  nonreducing 
(NR)-reducing (R) SDS-PAGE, and 
total protein was visualized. Positions 
of  CD3~'homodimers  (~'-~ and CD3~'- 
FcRT heterodimers  (~'-T) as well  as mo- 
lecular  size  markers  are indicated  in the 
figure. An off-diagonal  spot  with a mo- 
lecular mass of 14 kD seems to be an 
unknown molecule  detected  by the bi- 
otinylation method used. AI CD3~: Thymus 
Control  CD3  TCRcq~  TCRu 
-/- Z 
B  CD3~: Spleen 
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Figure  2.  Analysis  of NKI.1  + T cells in mice lacking CD3~" (A, B) 
or FcR"/(C).  Thymocytes  (.4, C) and splenocytes  (/3) from each line 
of mice were stained with FITC-anti-HSA  mAb, PE-anti-NKl.1 mAb, 
and biotin-anti-CD3e, -TCK-~, or -TCK-/~  mAb followed  by Tricolor- 
streptavidin. Expressions  of  NKI.1 (vertical)  and CD3, TCR-a/~, or TCR- 
"//~ (horizontal) on HSA- thymocytes  from each line of mice were illus- 
trated. Proportions  of upper-fight regions were indicated in the figure. 
The proportion  of NKI.I+ TCK-od~  + cells  to NKI.1- TCK-oUB  + cells 
in the thymus is 0.15 in ~'+1- and 0.05 in ~'-f- mice,  and that in the spleen 
is 0.041 in ~'+/- and 0.010 in ~'-/- mice. Data represent  five  independent 
experiments. 
TCR-3r/~ + thymocytes were calculated (Fig. 3). While the 
number  of NKI.1 +  TCR-oUB +  thymocytes was  reduced 
dramatically,  the  number  of NKI.1 +  TCR-3~/6 +  thymo- 
cytes increased about  six times in  ~'-/-  mice as compared 
with  those in  ~'+/- mice.  This expansion of the NKI.1 + 
TCR-'y//~ + thymocyte population was not simply a reflec- 
tion of a general increase of TCR-3U6 + T  cells in ~'-/- mice, 
as the number of NKI.1-  TCR-y//~ + thymocytes did not 
significantly increase in  g'-l-  mice, although their relative 
proportion within thymocytes increased (data not shown). 
Similar to thymocytes, the development of NKI.1 + TCR- 
ot/~ + T  cells was also arrested, and NKI.1 + TCR-'y/6 + T 
Figure 3.  Total  cell numbers ofNKl.1 + TCR-rv//~+ cells  and NKI.1  + 
TCR'y6+ cells  in the thymus of CD3~'-defident  mice. The total numbers 
of NKI.1  + TCR-oU/3+ thymocytes  and NKI.1  + TCR-3U~  + thymocytes 
from ~'+/- (n  =  7) and ~'-/- (n  z  6) mice were calculated. Data were 
presented as mean _+ SD. Significance  was evaluated  by Student's t test. 
cells  were increased in  the spleen of CD3~'-deficient mice 
(Fig.  2 B). 
When  FcR3~-deficient  mice were analyzed,  no obvious 
difference was  observed  in  the  development  of  NKI.1 + 
TCR-oUB + thymocytes as compared with wild-type mice 
(Fig.  2 C). In addition, the development of NKI.1 + TCR- 
3~//~  + thymocytes, though small in number, was not affected 
by the lack of FcR'y expression (Fig. 2 C).  These findings 
indicate that the expression of CD3~" is essential for the de- 
velopment  of  NKI.1 +  TCR-oU~ +  T  cells  but  not  of 
NKI.1 + TCIL-~//~ + thymocytes. On the other hand, FcR% 
though involved in the TCR complexes of NKI.1 + TCR- 
c~/~ +  T  cells,  was  not  crucial  for  the  development  of 
NKI.1 +  TCR-c~/3 + T  cells. 
Surface  Phenotype  of NKI.1 +  TCR-9//cJ +  Thymocytes  in 
CD3~'-deficient  Mice.  To  characterize  the  novel  NKI.1 + 
TCR-3,/6 +  thymocytes that  expanded in  CD3~'-deficient 
mice, we analyzed the expression of several surface markers 
on NKI.1 + TCR-3,/~ + thymocytes. As previously reported 
(3, 4, 10, 25), the surface phenotype of NKI.1 + TCR-~/fl + 
thymocytes is homogeneously CD8-  CD44 + MEL-14- Ib 
2RB + Ib7R +,  and almost half of them express CD4 (Fig. 
4). When the surface phenotype of NKI.1 + thymocytes in 
~'-/- mice (most were TCR-3,/~ + calls) was compared with 
that in ~'+/- mice (most were TCR-c~/~ § cells),  almost all 
of the NKI.1 + TCR-3,/6 § thymocytes were CD8-  CD44 + 
MEL-14- IL-2RB + IL-7R +  , which was the same phenotype 
as NKI.1 + TCR-oUfl  + thymocytes, except that most of the 
NKI.1 + TCR-3,/~ + thymocytes were CD4-  (Fig.  4). 
Discussion 
In  the  present  study,  we  found  that  freshly  isolated 
NKI.1 +  TCK-oUfl +  thymocytes express TCK complexes 
associated with CD3~'-FcR3' heterodimers as well as CD3~" 
homodimers.  Considering  that  TCK  complexes of most 
NKI.1-  T  cells do not contain FcR% NKI.1 + TCR-oUfl + 
thymocytes may possess  a unique TCR signaling pathway 
via  FcR%  However,  the  development of NKI.1 +  TCK- 
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Figure 4.  Surface  phenotype analysis of 
NKI.1 + thymocytes  from CD3~'-deficient 
mice. Thymocytes from  ~'+/- and  ~'-/- 
mice were stained with FITC-anti-HSA 
mAb,  PE-anti-NKl.1  raAb,  and  bi- 
otin-anti-CD4,  -CD8, -CD44,-MEb14, 
-IL2RB, or -IL7R mAb. Expressions of 
NKI.1  (vertical)  and  indicated markers 
(horizontal)  on HSA- thymocytes  were il- 
lustrated. 
o~//3 +  T  cells  was  almost  completely blocked  in  CD3~'- 
deficient mice, but not in FcR'y-deficient mice. These obser- 
vations demonstrated that the expression of CD3~" but not 
of FcR3, was  a primary  requisite  for  the  development  of 
NKI.1 + TCR-oJB + T cells. Since the proportion of thymic 
and splenic NKI.1 + TCR-cffB + T  cells to NKI.1-  TCR- 
c~/B + T  cells was severely reduced in CD3~'-deficient mice 
(Fig.  2, A  and B), the development of NKI.1 + TCR-c~//3 + 
T cells was more dependent on the expression of CD3~" than 
that  of NKI.1-  TCR-o~/13 + T  cells. 
In  parallel  with  the  developmental  arrest  of  NKI.1 + 
TCR-c~/B + T  cells, novel NKI.1 + TCR-~,/8 + T  cells were 
expanded in CD3~'-deficient mice. The NKI.1 + TCR--//6 + 
T cells showed almost the same phenotype as NKI.1 + TCR- 
c~/B + T cells, suggesting that they both belong to the same 
lineage.  The exact mechanism of the expansion of NKI.1 + 
TCR-'y//~ + thymocytes in CD3~'-deficient mice is not clear 
at present.  Considering  that  the number of TCR-3'/8 + T 
cells did not increase in the mice lacking TCR-cx/~ T  cells 
(26,  27),  and the number  of NKI.1-  TCR-'y/6 + thymo- 
cytes did not increase in our CD3~'-deficient mice, the ex- 
pansion of NKI.1 + TCR-'~/6 + T cells does not seem to be 
merely a compensation for the reduction of TCR-odB + T 
cells in CD3~'-deficient mice. Therefore, we assume that the 
expansion  of NKI.1 §  TCR-'y/~ + T  cells  may result from 
the lack of signals through CD3~'. It is possible that signals 
through  CD3~" on TCR-3,/6 + T  cells may inhibit  the de- 
velopment of NKI.1 + TCR-3,//~ + T  cells in normal mice. 
Indeed, recent observations that the overexpression of CD3~" 
suppressed the recombination-activating gene expression and 
blocked the development of TCR-cx/13 + T cells (28) are con- 
sistent with  this idea.  Therefore,  signals from CD3~" may 
regulate the development of thymocytes and T cells positively 
or negatively,  depending  on the developmental  stages and 
specific  properties of T  cell subsets. 
The development of NKI.1 + TCR-cx/3 + thymocytes was 
not altered in FcR3,-deficient mice (Fig. 2 B ). Furthermore, 
NKI.1 + TCR-o~/~ + thymocytes from FcRy-defident mice 
responded to the stimulation by immobilized anti-TCR mAb 
and had grown in the presence of IL-2 as in normal mice (Arose, 
H., and T. Saito, unpublished observation). Therefore, FcR3~ 
does not seem to be critical for the development and func- 
tion of NKI.1 + TCR-o~/B + T  cells.  However, considering 
that FcRy has an antigen recognition activation motif and 
transduces signals distinct from that through CD3~" in vitro 
(29),  it  may  contribute  partly  to  the  TCR  signaling  in 
NKI.1 + TCtL-oJj8 + thymocytes. Further studies will be re- 
quired to clarify the function of FcR3' expressed in NKI.1 + 
TCR-c~/13 + thymocytes. 
Collectively, it is concluded that at least three populations, 
NKI.1-  TCR-cffl3 + T  cells,  NKI.1 + TCR-cx/13 + T  cells, 
and  NKI.1 +  TCR-3//~ +  T  cells,  require  different  TCR 
signals for their development. Although the precise manner 
and location of the differentiation  of NKI.1 + TCR-oJB* 
T  cells and NKI.1 + TCR.-3,/~5 + T  cells are still unclear,  our 
present findings that CD3~" signals control the development 
of TCR-c~/t5 + and TCR-~/~ + T cells provide an important 
insight  into  the biology of NKI.1 §  T  cells. 
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